Kuiz berkaitan panduan · Sederhana Tahap

Kuiz Peraturan FDA bagi Peranti Perubatan AI

Menguji laluan 510(k), De Novo dan PMA, pelan kawalan perubahan yang telah ditetapkan untuk kemas kini AI, dan cara peraturan EU MDR dan AI Act digunakan pada peranti AI.

Laluan panduan yang berkaitanPeraturan FDA Peranti Perubatan AI
soalan 1 daripada 8

Apakah yang mesti ditunjukkan oleh pengilang untuk mendapatkan pelepasan 510(k)?

Pratonton setiap soalan8 soalan

Jawapan dan penjelasan muncul semasa anda mengambil kuiz.

  1. Apakah yang mesti ditunjukkan oleh pengilang untuk mendapatkan pelepasan 510(k)?
    • That the device is substantially equivalent to a legally marketed predicate device
    • That the device has completed three phases of randomized clinical trials
    • That the device has no predicate and is low to moderate risk
    • That the device learns continuously from patient data
  2. FDA membenarkan IDx-DR, AI autonomi untuk retinopati diabetik, pada 2018. Laluan manakah yang digunakannya, dan mengapa?
    • PMA, because every diagnostic AI is Class III
    • 510(k), because many retinal cameras already existed
    • De Novo, because it was novel and had no suitable predicate
    • It needed no authorization under the Cures Act exclusion
  3. Apakah yang dibenarkan oleh pelan kawalan perubahan yang telah ditetapkan (PCCP)?
    • Selling a device before the FDA has reviewed it
    • Making specified, pre-validated modifications to an AI device without a new submission for each one
    • Letting a model rewrite its own intended use in the field
    • Skipping postmarket monitoring
  4. Tiga bahagian yang manakah membentuk PCCP?
    • Predicate list, clinical trial, and labeling
    • Risk class, user fee, and establishment registration
    • Algorithm source code, training data, and patent filings
    • Description of modifications, modification protocol, and impact assessment
  5. Pernyataan yang manakah tentang kebanyakan peranti AI yang dibenarkan oleh FDA adalah tepat?
    • They are generally locked models that change only through controlled updates
    • They retrain themselves automatically on every patient they see
    • They are all Class III devices approved through PMA
    • They are mostly used in dermatology
  6. Under the 21st Century Cures Act, which kind of software can fall outside the definition of a device?
    • Software that analyzes medical images to detect tumors
    • Any software sold by a hospital
    • Clinical decision support that shows clinicians the basis for its recommendations so they can review them independently
    • Any software that uses machine learning
  7. Under the EU Medical Device Regulation, which rule classifies software, and where does most diagnostic software end up?
    • Rule 1, which puts it in Class I
    • Rule 11, which puts most of it in Class IIa or higher
    • Annex XVI, which exempts it
    • Rule 22, which places all software in Class III
  8. Why do reviewers ask for AI device performance broken down by subgroup and acquisition equipment?
    • To calculate user fees
    • To choose a predicate device
    • To decide whether the device is Class I
    • Because models can fail when patient populations or equipment such as scanner vendors differ from the training data